
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Oncol.
Sec. Cancer Epidemiology and Prevention
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1404686
This article is part of the Research Topic Advancing Collaborative Efforts in Cancer Research: A Convening of North-Eastern Nigeria Universities and International Health Systems on Etiology, Care, and Outcomes View all 9 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Haematological malignancies (HM) are primary cancers of blood and blood forming organs. They are heterogeneous and of diverse clinical features, treatment protocols and prognosis. They constitute a significant source of cancer related morbidity and mortality. Northeastern Nigeria, being the region in the country with the worst literacy rate and poverty indices is also battling with the burden of these diseases with the limited health facilities to adequately diagnose and treat these ailments. There is paucity of a comprehensive data on HMs in the region, so this study aims to report on the multicenter burden of the common HMs in the region and to discuss their patterns of distribution and management challenges.Materials and Methods: This was a five-year retrospective study where records of cases of HMs diagnosed in the four health facilities viz; Abubakar Tafawa Balewa University Teaching Hospital (ATBUTH) Bauchi, Federal Teaching Hospital (FTH), Gombe, Modibbo Adama University Teaching Hospital (MAUTH), Yola and Federal Medical Centre (FMC), Azare were collected from 1st January, 2018 to 31st December, 2022. Data on the age, gender, diagnosis as well as subtypes of some malignancies were also obtained and analyzed using SPSS Version 23.0 statistical software.Results: Four hundred and ninety-three (493) cases of HMs which constituted 8.2% of all cancers were diagnosed during the period under review. Paediatric HMs constituted 42.0% (207/493) of the HMs. Non-Hodgkin Lymphomas (NHL) constituted the majority of the HM 115/490 (23.5%) while Multiple Myeloma (MM) is the least 38/493 (7.7%). An average cost of 5,000 to 10,000 United State dollars is required to manage a HM in Nigeria. Late presentation of patients, non-availability and inadequate number of personnel, inability to pay for investigations and/or treatments due to financial constraints, limited facilities for tests such as flow cytometry, immunohistochemistry, cytogenetic and molecular genetic analyses were the challenges identified in the institutions in northeastern Nigeria that manage cancer patients.Conclusion: Haematological malignancies are common in our environment and there are limited facilities and expertise to accurately diagnose and treat them in the region and Nigeria in general.
Keywords: haematological malignancies, patterns, distribution, Challenges, Northeastern Nigeria
Received: 21 Mar 2024; Accepted: 10 Mar 2025.
Copyright: © 2025 Dachi, Mustapha, James, Pindiga, Ezenkwa, Yusuf, Yuguda and SULEIMAN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rufai Abdu Dachi, Abubakar Tafawa Balewa University, Bauchi, Nigeria
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.